Ebumab Holding ApS: Financial statements 2024
CVR: 39807556
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Ebumab Holding ApS (CVR 39807556) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -16,250 and a net result of DKK -39,197 compared with DKK 171,331 the year before. Equity in the 2024 report amounted to DKK 5,605,251. The solvency ratio was 98.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -16,250
- Profit/Loss
- DKK -39,197
- Equity
- DKK 5,605,251
- Total Assets
- DKK 5,683,543
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -16K | -39K | 5.6M | 1 |
| 2023 | 0 | -23K | 171K | 5.6M | 0 |
| 2022 | 0 | -57K | 100K | 5.5M | 0 |
| 2021 | 0 | -45K | 163K | 5.4M | 0 |
| 2020 | 785K | 392K | -337K | 5.2M | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Ebumab Holding ApS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK 171,331.
About Ebumab Holding ApS
Ebumab Holding ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Ikke-finansielle hovedsæders aktiviteter. The management consists of Hans Heugh Wandall and Johan Henrik Faber. The board consists of Hans Heugh Wandall (chair), Johan Henrik Faber, Mads Nikolaj Behrndt-Eriksen and Søren Erik Bjørn. The company's owners include Wandall Holding ApS, Johan H. Faber ApS and Batchelor Holding ApS. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -86,871 and a net result of DKK 75,634,949 compared with DKK -39,197 the year before. Equity in the 2025 report amounted to DKK 5,684,083.